The positive opinion for use of Cosentyx either alone or in combination with methotrexate has been given for the juvenile idiopathic arthritis (JIA) categories of enthesitis-related arthritis (ERA) The post Novartis’ Cosentyx gets CHMP positive opinion for use in childhood arthritic conditions appeared first on Pharmaceutical Business review. … [Read more...]
FDA Places Partial Clinical Hold on Foghorn’s AML and MDS Study Due to Patient Death
Patients currently enrolled in the study can continue to receive treatment, but no new patients can be enrolled. … [Read more...]
Drug Delivery West (5/23/22 – 5/24)
Artax Biopharma to develop oral small molecule immunomodulating agent
The company focuses on transforming the treatment of T Cell-mediated pathologies. New investors, Eli Lilly and Company and Sound Bioventures, took part in the financing round along with The post Artax Biopharma to develop oral small molecule immunomodulating agent appeared first on Pharmaceutical Business review. … [Read more...]
Moma Therapeutics completes funding for precision oncology programmes
The financing round saw participation from other new investors Pavilion Capital, Section 32, Invus and LifeSci Venture Partners. All of the Series A investors of Moma including Third The post Moma Therapeutics completes funding for precision oncology programmes appeared first on Pharmaceutical Business review. … [Read more...]